Published in Am J Med on February 27, 1984
ISA--vasodilatation: improvement of organ perfusion. Br J Clin Pharmacol (1987) 0.75
Molecular analysis of commensal host-microbial relationships in the intestine. Science (2001) 12.04
Morbidity and mortality in the Swedish Trial in Old Patients with Hypertension (STOP-Hypertension) Lancet (1991) 9.57
Coronary heart-disease after treatment of hypertension. Lancet (1978) 3.78
Treatment of severe refractory autoimmune hemolytic anemia in B-cell chronic lymphocytic leukemia with alemtuzumab (humanized CD52 monoclonal antibody). Leukemia (2007) 3.33
Effects of clonidine withdrawal: possible mechanisms and suggestions for management. Br Med J (1973) 2.87
1999 World Health Organization-International Society of Hypertension Guidelines for the management of hypertension. Guidelines sub-committee of the World Health Organization. Clin Exp Hypertens (1999) 2.72
Tumour markers in colorectal cancer: European Group on Tumour Markers (EGTM) guidelines for clinical use. Eur J Cancer (2007) 2.36
Hypertension is related to cognitive impairment: a 20-year follow-up of 999 men. Hypertension (1998) 2.31
Blood pressure crisis following withdrawal of clonidine (Catapres, Catapresan), with special reference to arterial and urinary catecholamine levels, and suggestions for acute management. Am Heart J (1973) 2.17
Home blood pressure determination. Value in borderline ("labile") hypertension. JAMA (1974) 2.16
Initial clinical experience with I.C.I. 66.082, a new beta-adrenergic blocking agent, in hypertension. Acta Med Scand (1973) 2.10
The 1993 guidelines for the management of mild hypertension: memorandum from a WHO/ISH meeting. Blood Press (1993) 2.03
Renal function and intensive lowering of blood pressure in hypertensive participants of the hypertension optimal treatment (HOT) study. J Am Soc Nephrol (2001) 1.94
"Tolerosomes" are produced by intestinal epithelial cells. Eur J Immunol (2001) 1.93
Clinical utility of biochemical markers in colorectal cancer: European Group on Tumour Markers (EGTM) guidelines. Eur J Cancer (2003) 1.86
Reversal of left ventricular hypertrophy in hypertensive patients. A metaanalysis of 109 treatment studies. Am J Hypertens (1992) 1.73
Regional intratidal gas distribution in acute lung injury and acute respiratory distress syndrome--assessed by electric impedance tomography. Minerva Anestesiol (2010) 1.71
Positive end-expiratory pressure optimization using electric impedance tomography in morbidly obese patients during laparoscopic gastric bypass surgery. Acta Anaesthesiol Scand (2006) 1.71
The Hypertension Optimal Treatment (HOT) Study--patient characteristics: randomization, risk profiles, and early blood pressure results. Blood Press (1994) 1.70
[There is no reason to avoid calcium antagonists in hypertension]. Lakartidningen (1996) 1.62
Clinical evaluation of a partial CO2 rebreathing technique for cardiac output monitoring in critically ill patients. Acta Anaesthesiol Scand (2002) 1.59
Initial clinical experience with ICI 141,292 (Visacor), a new selective beta 1-adrenoceptor blocker with ISA--a multicentre trial in 59 patients. Br J Clin Pharmacol (1984) 1.53
Metabolism and excretion of nitric oxide in humans. An experimental and clinical study. Circ Res (1993) 1.53
Relation between drug treatment and cancer in hypertensives in the Swedish Trial in Old Patients with Hypertension 2: a 5-year, prospective, randomised, controlled trial. Lancet (2001) 1.52
Warning! Suctioning. A lung model evaluation of closed suctioning systems. Acta Anaesthesiol Scand (2001) 1.49
Capsaicin-induced cough in humans. Am Rev Respir Dis (1992) 1.49
Reversal of cardiovascular structural changes when treating essential hypertension. The importance of the renin-angiotensin-aldosterone system. Am J Hypertens (1992) 1.48
Influence of gender and age on preventing cardiovascular disease by antihypertensive treatment and acetylsalicylic acid. The HOT study. Hypertension Optimal Treatment. J Hypertens (2000) 1.48
A 5-year prospective, observational study of the withdrawal of antihypertensive treatment in elderly people. J Intern Med (1994) 1.46
Risk factors associated with alterations in carotid intima-media thickness in hypertension: baseline data from the European Lacidipine Study on Atherosclerosis. J Hypertens (1998) 1.46
Organization and efficacy of an out-patient hypertension clinic. Acta Med Scand (1978) 1.45
Descending aortic blood flow and cardiac output: a clinical and experimental study of continuous oesophageal echo-Doppler flowmetry. Acta Anaesthesiol Scand (2001) 1.43
Noise as a contributory factor in the development of elevated arterial pressure. A study of the mechanisms by which noise may raise blood pressure in man. Acta Med Scand (1980) 1.42
Effects of dopamine, dopexamine and dobutamine on renal excretory function during experimental sepsis in conscious rats. Acta Anaesthesiol Scand (1997) 1.42
Direct tracheal airway pressure measurements are essential for safe and accurate dynamic monitoring of respiratory mechanics. A laboratory study. Acta Anaesthesiol Scand (2001) 1.41
A simplified method for separate measurements of lung and chest wall mechanics in ventilator-treated patients. Acta Anaesthesiol Scand (1999) 1.41
Controlled study of atenolol in treatment of hypertension. Br Med J (1975) 1.41
Small intestinal absorption of polyethylene glycol 400 to 1,000 in the portacaval shunted rat. Hepatology (1995) 1.39
Dead-space reduction and tracheal pressure measurements using a coaxial inner tube in an endotracheal tube. Intensive Care Med (2002) 1.39
A retrospective analysis of nitric oxide inhalation in patients with severe acute lung injury in Sweden and Norway 1991-1994. Acta Anaesthesiol Scand (1997) 1.38
Test characteristics of the Hopkins Symptom Check List-25 (HSCL-25) in Sweden, using the Present State Examination (PSE-9) as a caseness criterion. Soc Psychiatry Psychiatr Epidemiol (1993) 1.36
Twice-daily propranolol treatment for hypertension. Lancet (1971) 1.31
Hemodynamic effects of acute and prolonged beta-adrenergic blockade in essential hypertension. Acta Med Scand (1974) 1.28
Malignant hypertension--improving prognosis in a rare disease. Acta Med Scand (1979) 1.21
A comparison of the antihypertensive effect of atenolol (ICI 66 082) and propranolol. Eur J Clin Pharmacol (1976) 1.21
Effects of individual risk factors on the incidence of cardiovascular events in the treated hypertensive patients of the Hypertension Optimal Treatment Study. HOT Study Group. J Hypertens (2001) 1.19
Propranolol given twice daily in hypertension. Acta Med Scand (1973) 1.19
Serotoninergic mechanisms in hypertension. Focus on the effects of ketanserin. Hypertension (1988) 1.17
Haemodynamic effects of carvedilol, a new beta-adrenoceptor blocker and precapillary vasodilator in essential hypertension. J Hypertens (1984) 1.16
Oral tolerization with peptide 336-351 linked to cholera toxin B subunit in preventing relapses of uveitis in Behcet's disease. Clin Exp Immunol (2004) 1.16
STOP-Hypertension 2: a prospective intervention trial of "newer" versus "older" treatment alternatives in old patients with hypertension. Swedish Trial in Old Patients with Hypertension. Blood Press (1993) 1.15
STOP-Hypertension--preliminary communication from the pilot study of the Swedish Trial in Old Patients with Hypertension. J Hypertens Suppl (1987) 1.14
Thoracic epidural anesthesia during coronary artery bypass surgery: effects on cardiac sympathetic activity, myocardial blood flow and metabolism, and central hemodynamics. Anesth Analg (1994) 1.14
Renal sympathetic activity in spontaneously hypertensive rats and normotensive controls, as studied by three different methods. Acta Physiol Scand (1984) 1.14
Regional haemodynamic effects of endothelin-1 in rat and man: unexpected adverse reaction. J Hypertens (1990) 1.13
The relevance of tissue angiotensin-converting enzyme: manifestations in mechanistic and endpoint data. Am J Cardiol (2001) 1.12
Beta-adrenergic blockade in essential hypertension. Effects of propranolol on hemodynamic parameters and plasma renin activity. Acta Med Scand Suppl (1973) 1.10
Objective social outcomes index (SIX): a method to summarise objective indicators of social outcomes in mental health care. Acta Psychiatr Scand (2008) 1.10
Increased frequency of activated T-cells in the Helicobacter pylori-infected antrum and duodenum. FEMS Immunol Med Microbiol (2003) 1.09
Hypertension in the elderly. Hypertension seminars at Ostra Hospital, Göteborg, Sweden. Acta Med Scand (1981) 1.09
Prolonged exposure to a stressful stimulus (noise) as a cause of raised blood-pressure in man. Lancet (1977) 1.09
Antihypertensive mechanism of beta-adrenoceptor antagonism--the role of beta 2-blockade. J Hypertens Suppl (1983) 1.08
Does drug treatment improve survival in mild-to-moderate hypertension? J Hypertens (1995) 1.07
Relation of maternal blood pressure during pregnancy to birth weight and blood pressure in children. The Hypertension in Pregnancy Offspring Study. J Intern Med (1994) 1.07
Changes in glycosylation of human bile-salt-stimulated lipase during lactation. Arch Biochem Biophys (2000) 1.07
Conversion of inhaled nitric oxide to nitrate in man. Br J Pharmacol (1995) 1.06
Microsatellite instability did not predict individual survival of unselected patients with colorectal cancer. Int J Colorectal Dis (2006) 1.06
Diet and the risk of papillary and follicular thyroid carcinoma: a population-based case-control study in Sweden and Norway. Cancer Causes Control (1997) 1.06
Ketanserin in hypertension. Early clinical evaluation and dose finding study of a new 5-HT2 receptor antagonist. Acta Med Scand (1983) 1.05
Long-term effects of losartan on blood pressure and left ventricular structure in essential hypertension. J Hum Hypertens (1996) 1.04
The Nordic Study on schizophrenic patients living in the community. Subjective needs and perceived help. Eur Psychiatry (2001) 1.02
The validity of Antonovsky's Sense of Coherence measure in a sample of schizophrenic patients living in the community. J Adv Nurs (2001) 1.02
Prediction of later hypertension following a hypertensive pregnancy. J Hypertens Suppl (1983) 1.02
Primary hypertension refractory to triple drug treatment: a study on central and peripheral hemodynamics. Circulation (1978) 1.01
Psychiatric morbidity in primary public health care: a multicentre investigation. Part II. Hidden morbidity and choice of treatment. Acta Psychiatr Scand (1997) 1.01
Psychiatric morbidity in primary public health care: a Nordic multicentre investigation. Part I: method and prevalence of psychiatric morbidity. Acta Psychiatr Scand (1995) 1.00
Captopril and atenolol combined with hydrochlorothiazide in essential hypertension. Br J Clin Pharmacol (1982) 1.00
Quantitative and qualitative aspects of the social network in schizophrenic patients living in the community. Relationship to sociodemographic characteristics and clinical factors and subjective quality of life. Int J Soc Psychiatry (2001) 0.98
Reproductive history and cigarette smoking as risk factors for thyroid cancer in women: a population-based case-control study. Cancer Epidemiol Biomarkers Prev (1996) 0.98
Propranolol in hypertension. Report on 158 patients treated up to one year. Klin Wochenschr (1972) 0.97
Controlled trial of nifedipine and bendroflumethiazide in hypertension. J Cardiovasc Pharmacol (1984) 0.96
Clinical and social needs of schizophrenic outpatients living in the community: the relationship between needs and subjective quality of life. Soc Psychiatry Psychiatr Epidemiol (1999) 0.96
Patient satisfaction with inpatient psychiatric care. The influence of personality traits, diagnosis and perceived coercion. Acta Psychiatr Scand (1994) 0.96
The effct of propranolol on plasma renin activity and blood pressure in mild essential hypertension. Acta Med Scand (1974) 0.95
Controlled trial of acebutolol in hypertension. Eur J Clin Pharmacol (1977) 0.95
Blood pressure reduction and vascular adaptation. A study on long-term effects of treatment with mefruside or atenolol. Acta Med Scand (1979) 0.95
Accuracy of a first diagnosis of asthma in primary health care. Fam Pract (2002) 0.95
Human milk kappa-casein and inhibition of Helicobacter pylori adhesion to human gastric mucosa. J Pediatr Gastroenterol Nutr (1995) 0.95
A distal enhancer region in the human beta-casein gene mediates the response to prolactin and glucocorticoid hormones. Gene (1998) 0.95
Evaluation of a new system for ventilatory administration of nitric oxide. Acta Anaesthesiol Scand (1993) 0.95
Hypertensive retinal vascular changes: relationship to left ventricular hypertrophy and arteriolar changes before and after treatment. Blood Press (1992) 0.94
Increased abdominal obesity, adverse psychosocial factors and shorter telomere length in subjects reporting early ageing; the MONICA Northern Sweden Study. Scand J Public Health (2008) 0.94
Kinetics of cytokine gene expression in human CD4+ and CD8+ T-lymphocyte subsets using quantitative real-time PCR. Scand J Immunol (2003) 0.94
Metoprolol and pindolol in hypertension: different effects on peripheral haemodynamics. Clin Sci (Lond) (1981) 0.94
Anastomotic-vaginal fistula (AVF) after anterior resection of the rectum for cancer--occurrence and risk factors. Colorectal Dis (2009) 0.94
Enhanced pressor responses to experimental and daily-life stress in borderline hypertension. J Hypertens (1995) 0.92
Bronchoscopic suctioning may cause lung collapse: a lung model and clinical evaluation. Acta Anaesthesiol Scand (2007) 0.92
Bracing versus nonbracing in rehabilitation after anterior cruciate ligament reconstruction: a randomized prospective study with 2-year follow-up. Knee Surg Sports Traumatol Arthrosc (2001) 0.92
Identification of the binding site for a low-molecular-weight inhibitor of plasminogen activator inhibitor type 1 by site-directed mutagenesis. Biochemistry (1998) 0.91